MISTY PHILLIPS: Open Payments
NPI 1124678156 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,934 in 122 payments from 13 companies in 2025. Trend: 2023 $295 · 2024 $1,968 · 2025 $1,934
Food & beverage: $1,825Education: $109
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $300 |
| ABBVIE INC. | 20 | $259 |
| GENZYME CORPORATION | 12 | $211 |
| Novartis Pharmaceuticals Corporation | 9 | $208 |
| Galderma Laboratories, L.P. | 21 | $196 |
| UCB, Inc. | 11 | $156 |
| E.R. Squibb & Sons, L.L.C. | 10 | $149 |
| Arcutis Biotherapeutics, Inc. | 11 | $148 |
| Regeneron Healthcare Solutions, Inc. | 5 | $113 |
| Lilly USA, LLC | 6 | $98 |
Products named: DUPIXENT, TREMFYA, Bimzelx, Sotyktu, Zoryve, NEMLUVIO, SKYRIZI, RINVOQ.
Industry payments across TX — which companies pay providers there.
